| Bioactivity | Piragliatin (RO4389620) is an activator for glucokinase, which reduces endogenous glucose production, increases β-cell function and glucose utilization, and thus decreases the blood glucose levels. Piragliatin exhibits antidiabetic efficacy[1]. |
| CAS | 625114-41-2 |
| Formula | C19H20ClN3O4S |
| Molar Mass | 421.90 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Bonadonna RC, et al., Piragliatin (RO4389620), a novel glucokinase activator, lowers plasma glucose both in the postabsorptive state and after a glucose challenge in patients with type 2 diabetes mellitus: a mechanistic study. J Clin Endocrinol Metab. 2010 Nov;95(11):5028-36. |
Piragliatin
CAS: 625114-41-2 F: C19H20ClN3O4S W: 421.90
Piragliatin (RO4389620) is an activator for glucokinase, which reduces endogenous glucose production, increases β-cell
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.